Literature DB >> 3057060

Transplantation of the liver in adults and children with fulminant hepatic failure.

C Vickers1, J Neuberger, J Buckels, P McMaster, E Elias.   

Abstract

Fulminant hepatic failure has a high mortality rate despite intensive medical treatment. Urgent hepatic transplantation was considered over a 3 year period in 26 (36%) of 73 patients with the worst prognostic features of fulminant hepatic failure. The criteria for patient selection were based on the duration of advanced hepatic coma and the deterioration of liver function. Sixteen patients were transplanted, and 9 (56%) are currently alive. The median duration of follow-up is 16 months and actuarial 1 year survival 55%. Six patients died because of the absence of offers of organ donation. Twenty-two (85%) of the 26 patients considered were referred with advanced encephalopathy or hepatorenal syndrome. Of the 57 patients not transplanted, 18 (95%) of 19 patients with grade I/II encephalopathy survived compared to 13 (34%) of 38 patients with grade III/IV encephalopathy. Transplantation does improve the chance of survival in selected patients with fulminant hepatic failure, early referral and availability or organ donation being important factors.

Entities:  

Mesh:

Year:  1988        PMID: 3057060     DOI: 10.1016/s0168-8278(88)80475-6

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  16 in total

1.  Liver transplantation and artificial liver support in fulminant hepatic failure.

Authors:  X F Zhu; G H Chen; X S He; M Q Lu; G D Wang; C J Cai; Y Yang; J F Huang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 2.  Animal models of fulminant hepatic failure.

Authors:  J Terblanche; R Hickman
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

3.  Liver transplantation after paracetamol overdose.

Authors:  J G O'Grady; J Wendon; K C Tan; D Potter; S Cottam; A T Cohen; A E Gimson; R Williams
Journal:  BMJ       Date:  1991-07-27

Review 4.  Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure.

Authors:  Man-Fung Yuen
Journal:  Hepatol Int       Date:  2014-09-21       Impact factor: 6.047

Review 5.  Acute hepatic failure: limitations of medical treatment and indications for liver transplantation.

Authors:  M Peters; K H Meyer zum Büschenfelde; G Gerken
Journal:  Clin Investig       Date:  1993-11

6.  Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix.

Authors:  M Nagaki; K Miki; Y I Kim; H Ishiyama; I Hirahara; H Takahashi; A Sugiyama; Y Muto; H Moriwaki
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

7.  Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure.

Authors:  Yao-Li Cui; Fang Yan; Yue-Bin Wang; Xue-Qin Song; Li Liu; Xue-Zhong Lei; Ming-Hua Zheng; Hong Tang; Ping Feng
Journal:  Dig Dis Sci       Date:  2010-05-29       Impact factor: 3.199

8.  Liver transplantation for fulminant hepatitis at Stanford University.

Authors:  Amy Lu; Humberto Monge; Kenneth Drazan; Maria Millan; Carlos O Esquivel
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

9.  Association of tumor necrosis factor-alpha gene promoter polymorphisms with acute viral hepatitis in the Indian population.

Authors:  Shashideep Singhal; Indu Kohaar; Mausumi Bharadwaj; Deepak K Shukla; Bhudev C Das; Premashis Kar
Journal:  Dig Dis Sci       Date:  2009-04-24       Impact factor: 3.199

10.  Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience.

Authors:  H Bismuth; D Samuel; D Castaing; R Adam; F Saliba; M Johann; D Azoulay; B Ducot; L Chiche
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.